A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: day (1000), time (1000)

Abdominal aortic aneurysm repair - patient information

Description
Information about abdominal aortic aneurysm repair
Url
/Media/UHS-website-2019/Patientinformation/Cardiovascular-and-thoracic/Abdominal-aortic-aneurysm-repair-1654-PIL.pdf

Adult hydrocephalus and shunts - patient information

Description
Hydrocephalus is a condition in which cerebrospinal fluid (CSF) builds up within the brain.
Url
/Media/UHS-website-2019/Patientinformation/Brain-and-spine/Adult-hydrocephalus-and-shunts-1520-PIL.pdf

Pembrolizumab2mg/kg

Description
Chemotherapy Protocol LUNG CANCER Pembrolizumab (2mg/kg) Regimen • NSCLC – Pembrolizumab (2mg/kg) Indication • Pembrolizumab is recommended as an option for treating
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Pembrolizumab2mgkg.pdf

Atezolizumab1680mg

Description
Chemotherapy Protocol LUNG CANCER Atezolizumab (1680mg 28 days) Regimen • Lung – Atezolizumab Indication • Atezolizumab is indicated for treating previously platinum-treated locally
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Atezolizumab1680mg.pdf

Pembrolizumab 400mg (bladder)

Description
Chemotherapy Protocol BLADDER CANCER Pembrolizumab (400mg) Regimen • Bladder – Pembrolizumab (400mg) Indication • Pembrolizumab is indicated for locally advanced (ie T4b any N
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Bladdercancer/Pembrolizumab-400mg.pdf

Pembrolizumab 200mg (bladder)

Description
Chemotherapy Protocol BLADDER CANCER Pembrolizumab (200mg) Regimen • Bladder – Pembrolizumab (200mg) Indication • Pembrolizumab is indicated for locally advanced (ie T4b any N
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Bladdercancer/Pembrolizumab-200mg.pdf

Atezolizumab(1680-28days)

Description
Chemotherapy Protocol GENITOURINARY CANCER Atezolizumab (1680mg-28 days) Regimen • Urothelial– Atezolizumab (1680mg-28 days) Indication • This protocol was developed in response
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Bladdercancer/Atezolizumab1680-28days.pdf

RPMitCEBO-Bleomycin-Cyclophosphamide-Etoposide-Mitoxantrone-Prednisolone-Rituximab-Vincristine Ver 1.4

Description
Chemotherapy Protocol LYMPHOMA BLEOMYCIN-CYCLOPHOSPHAMIDE-ETOPOSIDE-MITOXANTRONE-PREDNISOLONERITUXIMAB-VINCRISTINE (RPMitCEBO) Regimen  Lymphoma – RPMitCEBO-Bleomycin-Cyclophosphamide-Etoposide-MitoxantronePrednisolone-Rituximab-Vincristine Indication  CD20
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/RPMitCEBO-Bleomycin-Cyclophosphamide-Etoposide-Mitoxantrone-Prednisolone-Rituximab-Vincristine-Ver-1.4.pdf

RPACEBOM - Bleomycin-Cyclophosphamide-Doxorubicin-Etoposide-Methotrexate-Prednisolone-Rituximab-Vincristine

Description
Chemotherapy Protocol LYMPHOMA BLEOMYCIN-CYCLOPHOSPHAMIDE-DOXORUBICIN-ETOPOSIDE-METHOTREXATEPREDNISOLONE-RITUXIMAB-VINCRISTINE Regimen (RPACEBOM) Lymphoma – RPACEBOM-Bleomycin-Cyclophosphamide-Doxorubicin-EtoposideMethotrexate-Prednisolone-Rituximab-Vincristine
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/RPACEBOM-Bleomycin-Cyclophosphamide-Doxorubicin-Etoposide-Methotrexate-Prednisolone-Rituximab-Vincristine.pdf

InP RIVAC (66) cytarabine etoposide ifosfamide rituximab

Description
Chemotherapy Protocol LYMPHOMA CYTARABINE-ETOPOSIDE-IFOSFAMIDE-RITUXIMAB (RIVAC) 66 years and above Inpatient Regimen There are multiple versions of this protocol
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/InP-RIVAC-66-cytarabine-etoposide-ifosfamide-rituximab.pdf
641 to 650 of 986
Previous … 63 64 65 66 67 … Next